Submitted by Anonymous (not verified) on 10 September 2026 - 13:45
Human medicines European public assessment report (EPAR): Tagrisso, osimertinib, Date of authorisation: 01/02/2016, Revision: 25, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Tagrisso, osimertinib, Date of authorisation: 01/02/2016, Revision: 25, Status: Authorised